An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) will announce its third quarter 2021 financial and operational results on November 3, 2021, after market close. A conference call will commence at 4:30 p.m. ET the same day, with access via phone or a live audio webcast. The company focuses on enhancing surgical outcomes through its Performance-Guided Surgery™ initiative, utilizing the Senhance® Surgical System and Intelligent Surgical Unit™ (ISU™) technology. For more details, visit www.asensus.com.
Positive
Plans to release Q3 2021 results on November 3, 2021, indicating ongoing operations and transparency.
Focus on Performance-Guided Surgery and use of advanced technology in surgery hints at potential for improved market position.
Negative
None.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-4304 for international callers, and reference conference ID 10016621 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link https://ir.asensus.com/events-and-presentations. The replay will be available on the Company’s website.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the clinical intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
